Eyenovia to Present at the American Academy of Optometry’s Annual Meeting

Rhea-AI Summary

On October 21, 2022, Eyenovia, Inc. (NASDAQ: EYEN) announced its participation at the 2022 American Academy of Optometry’s Annual Meeting from October 26-29, 2022, in San Diego. The company will showcase its Optejet^® drug delivery system, presenting a virtual press conference titled Eyenovia - The Optejet® Evolving Drug Delivery to Support Optometric Advancement on October 25, 2022. Additionally, Peter Lam, PhD, will present a paper on Aerial Bioburden Monitoring on October 27. For more details, visit Eyenovia.com.

NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet^® delivery system for use both in combination with its own drug-device therapeutic programs as well as out-licensing for additional indications, today announced the company will present at the 2022 American Academy of Optometry’s Annual Meeting, which is taking place from October 26-29, 2022, at the at the San Diego Convention Center. Presentation details are below:

2022 American Academy of Optometry Virtual Press Conference

Presentation Title:	Eyenovia - The Optejet® Evolving Drug Delivery to Support Optometric Advancement
Presenter:	Beth Scott, OD, FAAO, VP Regulatory and Medical Affairs
Date and Time:	Tuesday, October 25, 5:00 pm to 7:00 pm PST
Link:	Here

2022 American Academy of Optometry Annual Meeting

Paper Title:	Aerial Bioburden Monitoring within Optometric Offices during Normal Office Hours
Presenting author:	Peter Lam, PhD
Session: Date and Time:	P-11: Papers: Screening & Public Health on October 27, 4:00pm PT
Location:	Room 29AB

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit Eyenovia.com.

The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.

Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com

Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363

Eyenovia Media Contact:
Eyenovia, Inc.
Norbert Lowe
Vice President, Commercial Operations
nlowe@eyenovia.com

FAQ

What is the presentation title Eyenovia will showcase at the 2022 American Academy of Optometry?

Eyenovia will present 'Eyenovia - The Optejet® Evolving Drug Delivery to Support Optometric Advancement.'

When is Eyenovia's press conference scheduled at the 2022 American Academy of Optometry?

Eyenovia's press conference is scheduled for October 25, 2022, from 5:00 pm to 7:00 pm PST.

What paper will Peter Lam present at the American Academy of Optometry Annual Meeting?

Peter Lam will present a paper titled 'Aerial Bioburden Monitoring within Optometric Offices during Normal Office Hours.'

When and where will Peter Lam's presentation take place?

His presentation is on October 27, 2022, at 4:00 pm PT in Room 29AB.

What is Eyenovia's focus as a company?

Eyenovia focuses on developing a pipeline of microdose array print (MAP™) therapeutics for ophthalmic conditions.